| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |